IsraelLawThousands of foreign businesspeople serve as directors or officers of Israeli companies: nominees appointed by an overseas parent, investors who took a board seat in an Israeli startup, founders who incorporated in Israel to access local capital markets. Most of them have only a general sense that Israeli corporate law imposes personal duties, and assume their home-country experience with director liability applies. It largely does not.
Israeli company law has roots in British company law but has developed its own case law through the Supreme Court and Tel Aviv District Court (Economic Division). That body of law sharpened considerably after the 1999 Companies Law reforms and the introduction of the derivative suit and class action mechanisms that made director liability claims practical. What follows covers where that exposure actually sits and what can be done about it.
1. The Director Liability Framework Under Israeli Law
Israeli company law draws a fundamental distinction between liability to the company (and through the company, to shareholders) and liability to third parties such as creditors, employees, and the tax authority. The two channels have different legal bases and produce different practical risks.
Liability to the company and shareholders arises under Sections 252–259 of the Companies Law 5759-1999. A director who breaches the duty of care or the duty of loyalty is liable to the company for any loss caused. Shareholders can enforce this liability through the derivative suit mechanism under Section 194 — one shareholder suing on behalf of the company — or, where multiple shareholders are affected, through a class action under the Securities Law or the Class Actions Law 5766-2006.
Liability to third parties arises in more limited circumstances: primarily through tort law (the Civil Wrongs Ordinance), specific statutory provisions that impose personal liability for company debts (the tax and wage regimes described below), and the court's equitable jurisdiction to pierce the corporate veil in cases of abuse.
Most substantive corporate disputes in Israel — derivative suits, oppression petitions, D&O claims, and insolvency-related director liability — are heard by the Economic Division of the Tel Aviv District Court (Beit Mishpat Mechoz Tel Aviv — HaMachala HaKalkalit), located at Weizmann 1, Tel Aviv. This specialized court has developed a sophisticated body of case law on director duties since 1999. Foreign directors should be aware that Israeli litigation timelines are long (complex cases take 3 to 7 years), legal costs are significant, and the derivative suit mechanism means a single activist shareholder holding even a small stake can commence proceedings without the director being informed in advance. Appointing an Israeli litigation lawyer as a matter of course — not only when a claim arrives — is the best way to monitor exposure.
2. Fiduciary Duties: The Duty of Care and Duty of Loyalty
Every Israeli director and officer owes two core duties to the company under the Companies Law:
Duty of care (Section 252). A director must act with the level of competence that a reasonable director in the same position would bring, and must take all reasonable steps to obtain information relevant to decisions before they are made. The standard is objective — it does not depend on the individual director's subjective skills — but it is applied contextually: a more qualified director is held to a higher standard. The duty of care extends to monitoring the company's affairs: a director who genuinely delegates a function must still maintain oversight and cannot simply ignore warning signs.
Duty of loyalty (Section 254). A director must act in good faith in the company's best interests, must avoid conflicts of interest between personal interests and the company's interests, must not exploit business opportunities that belong to the company, and must not compete with the company in its area of activity. The duty of loyalty is stricter than the duty of care — breach of loyalty is not protected by the business judgment rule and the burden of proof shifts to the director to show the transaction was fair.
These duties apply to every director, whether resident in Israel or abroad, whether executive or non-executive, and whether appointed by a controlling shareholder or elected by the general meeting. A director who has taken the title without exercising any real oversight function is not thereby exempt — Israeli courts have imposed liability on nominee directors and rubber-stamp directors who failed to ask basic questions about transactions that, on the face of the board papers, should have raised concerns.
A foreign director who attends Israeli board meetings by video call once a quarter and receives board materials a week in advance satisfies the minimum formal requirements. The exposure is at the other end: a director who repeatedly misses meetings, does not read materials, and approves every resolution by written consent without review cannot later claim ignorance if those resolutions turn out to be wrongful. The Companies Law requires the board to meet at a minimum frequency set by the articles (typically quarterly for private companies), and a director's failure to attend even one meeting in a year must be excused formally — under Section 103(f), a director who does not attend may still be counted for quorum if the articles permit, but that does not discharge the director's substantive duties. Keep attendance records, read board papers, and document your questions and reservations — Israeli courts look at contemporaneous board minutes when assessing director conduct.
3. The Business Judgment Rule
The business judgment rule in Section 52(c) of the Companies Law is the main protection directors have for genuine commercial decisions. An Israeli court will not second-guess a business decision and impose director liability if all of the following are true:
- The director had no personal interest in the outcome of the decision.
- The director made a reasonable effort to obtain the information needed to make the decision.
- The director acted in good faith and genuinely believed the decision was in the company's best interests.
When those conditions are met, courts defer: even if the decision turned out badly, the director is not liable for the loss. Boards are not guarantors of outcomes.
The rule breaks down when any condition is missing. The most common problem is an undisclosed conflict of interest: once a personal stake appears, the business judgment rule does not apply and the director must prove the transaction was entirely fair to the company. The second common failure is cutting corners on information: a board that approved a major acquisition without any independent valuation, legal review, or financial analysis cannot claim it made an "informed" decision.
The business judgment rule is applied on the basis of what the board knew and did before the decision, not after. A board that commissioned a fairness opinion from a licensed Israeli accountant or appraiser (shama'i), reviewed independent legal advice, asked management questions reflected in the board minutes, and recorded a genuine deliberation is well-protected even if the outcome is poor. A board that received a one-page management summary, met for 20 minutes, and approved everything on the agenda is much more vulnerable. For significant Israeli subsidiary decisions — acquisitions, related-party transactions, major contracts — ask for written opinions, circulate them in advance of the meeting, and ensure the minutes reflect the substantive discussion that took place. These records become the primary evidence in any subsequent director liability claim.
4. Conflicts of Interest and the Approval Regime for Interested-Party Transactions
Israeli company law has an elaborate approval regime for transactions in which a director or officer has a personal interest — called iska she'yesh la director inyan ishi ba (an interested-party transaction). The regime is set out in Sections 255–275 of the Companies Law and varies depending on the type of transaction and whether the company is public or private.
For private companies, the key rules are:
- Disclosure obligation (Section 269): A director who has a personal interest in a proposed transaction must disclose this to the board before the board discusses it. Failure to disclose is itself a breach of the duty of loyalty.
- Board approval (Section 270): Transactions with a personal interest (other than non-material routine transactions on market terms) require board approval, with the interested director abstaining from the vote.
- Shareholder approval (Section 275): Transactions of a certain significance — those with a controlling shareholder or those involving director remuneration — require shareholder approval at a general meeting, in addition to board approval.
A transaction approved through the correct procedure is protected even if it later appears that the terms were less than optimal for the company. A transaction that was not properly approved — even if fair — exposes the interested director to liability and may be voided by the court.
A common scenario for foreign directors: the overseas parent company sells goods or services to its Israeli subsidiary at prices set by the group — a standard intercompany arrangement. In the Israeli subsidiary, the parent's nominee director(s) sitting on the board have a personal interest in those transactions (they serve the parent, which is the counterparty). Each such transaction requires disclosure by the interested directors and board approval by the disinterested directors. For groups with repeated intercompany sales, the cleanest approach is a framework approval: the Israeli board — with the interested directors abstaining — approves the general intercompany arrangement and its pricing terms for a defined period (typically one year), and individual transactions within those terms are then covered by the framework approval without needing individual board resolutions. The Israeli company secretary or general counsel should maintain a conflict register updated before each board meeting.
5. Personal Liability for Company Tax and Wages
Two statutory regimes impose personal liability on directors for company obligations (regardless of the corporate veil), and both regularly catch foreign directors off guard.
Tax liability under Section 119A of the Income Tax Ordinance. The Israel Tax Authority can assess a director, officer, or any person who was "involved in running the affairs" of the company personally for unpaid income tax and withholding tax (*nikui bemkor*) that the company failed to remit. The ITA uses this power primarily when the company has become insolvent or has been struck off, and the argument is that the director controlled the company's bank accounts and chose to pay other creditors in preference to the ITA. Personal assessments under Section 119A are not rare — the ITA issues several hundred per year, covering directors of companies that failed to remit employee withholding tax (bituach leumi contributions and income tax deducted at source from salaries). The same section extends to VAT arrears via a cross-reference in the VAT Law.
Wage liability under Section 29 of the Wage Protection Law 5718-1958. A director, manager, or partner who had the authority to prevent the non-payment of wages is personally liable, jointly with the company, for wages that were not paid when due. The National Labor Court has upheld wage claims against individual directors — including foreign directors of Israeli subsidiaries — where the director had signatory authority over the company's bank account and chose not to pay wages while the company was in financial difficulty. The personal liability here covers base salary, overtime, and statutory social benefits (pension contributions, severance accrual, sick pay), but not equity compensation or discretionary bonuses.
When the ITA issues a Section 119A assessment against a director, it sends a formal demand letter stating the amounts owed (typically the company's total unpaid withholding tax for a period, plus CPI linkage and interest at approximately 4% plus the Bank of Israel rate). The director has 30 days to file an objection (hashagah) with the local ITA assessing officer. The objection must explain why the director should not be personally liable — the most common defenses are that the director did not have actual control over the company's payments, that the company paid all obligations it legally could given available funds, or that an error was made in the underlying tax assessment. A director who ignores the Section 119A demand and does not object within 30 days loses the right to appeal and the assessment becomes final. Israeli courts have upheld ITA assessments against foreign directors who claimed they did not understand the document because it was in Hebrew — keep a licensed Israeli accountant on retainer for exactly this reason.
6. Piercing the Corporate Veil
Israeli courts pierce the corporate veil and hold directors or shareholders personally liable for company debts in a narrow set of circumstances. The doctrine is codified in Section 6 of the Companies Law, which allows a court to disregard the separate legal personality of a company when it was used to deceive creditors or to circumvent a legal obligation in a way that would be unjust to maintain.
Israeli courts have pierced the veil in the following recurring patterns:
- A director or shareholder who commingled personal and corporate assets — using the company bank account as a personal account or transferring company assets to personal accounts immediately before insolvency.
- A company established specifically to insulate a recurring business from the creditors of a previous failed company run by the same director — the "phoenix company" pattern.
- A director who caused the company to enter a transaction the director knew could not be performed, and who benefited personally from advance payments collected from the counterparty.
- A wholly-owned subsidiary used by the parent to perform acts that the parent was legally prohibited from performing — the court pierces in both directions, exposing the parent to the subsidiary's liabilities.
The standard is high. An honest business failure with a clean paper trail rarely triggers it. The risk is real, though, for foreign directors who have been casual about separating the Israeli subsidiary's finances from group accounts, or who have transferred subsidiary assets to the parent without proper consideration.
7. Indemnification Under the Companies Law
The Companies Law gives Israeli companies two tools to protect directors: a release from liability and an indemnification undertaking.
Release from liability (Section 259). A company may, in its articles of association, release directors from liability for breach of the duty of care (not the duty of loyalty, which cannot be released). The articles of most Israeli companies formed for foreign investors include a broad duty-of-care release for directors. Check your Israeli subsidiary's articles of association — if the release clause is absent, the board should consider adding it at the next general meeting.
Indemnification undertaking (Section 253). A company may commit in advance to indemnify a director for:
- Financial liability imposed on the director by a court judgment in a proceeding related to acts done in the capacity of director.
- Reasonable legal costs (including attorney fees) incurred defending against a proceeding, whether the proceeding succeeds or not.
- Payments made to settle a claim, provided the settlement is approved by a court.
The advance indemnification undertaking must specify a monetary ceiling — either a fixed NIS amount or a percentage of the company's shareholders' equity. For a private subsidiary of a foreign company, common practice is to set the ceiling at 25% to 50% of shareholders' equity, with a minimum floor of NIS 5 million to NIS 10 million regardless of equity level. Shareholder approval is required before any payment is made under the undertaking — the undertaking itself can be in the articles or a separate board resolution, but the actual payment requires a general meeting vote.
A foreign parent appointing employees as nominee directors of its Israeli subsidiary should ensure the Israeli subsidiary's articles include both a duty-of-care release and an advance indemnification undertaking before the directors take up their appointments — not after a claim arises. The undertaking should cover reasonable legal costs (Sections 253(a)(1)–(a)(2) of the Companies Law) and financial liability on a judgment (Section 253(a)(3)), with a ceiling of at least NIS 10 million. The parent company should also consider whether its group D&O policy covers Israeli subsidiary director liability, or whether a separate Israeli policy is needed (see Section 8 below). An Israeli corporate lawyer can prepare a board resolution and articles amendment for this purpose in 2 to 3 days; it is a routine task that costs a fraction of any subsequent litigation.
8. D&O Insurance in Israel
Section 258 of the Companies Law expressly authorizes Israeli companies to purchase directors' and officers' liability insurance (bituach achriut nosim misra). D&O coverage for Israeli companies is commercially available from major Israeli insurers (Migdal, Harel, Phoenix, Clal) and from international carriers writing Israeli risks through brokers. The market has matured significantly since 2010, and most mid-size Israeli private companies with foreign shareholders now carry at least a basic D&O policy.
A typical Israeli D&O policy covers:
- Personal liability of directors and officers not indemnified by the company (Side A coverage).
- Amounts the company pays as indemnification on behalf of its directors (Side B coverage).
- Securities claims against the company itself in some policies (Side C, more common for public companies).
Key points for foreign directors:
- Verify territorial scope. Some group D&O policies issued in the US or UK exclude Israeli subsidiary liability or treat it as a sublimit. Read the policy schedule carefully and confirm that Israeli company directorship is expressly covered.
- Check the definition of "wrongful act." Israeli policies typically define this to include breach of duty, error, misstatement, misleading statement, omission, and neglect — consistent with Sections 252–254 of the Companies Law.
- Understand Side A coverage. If the company cannot or will not indemnify (for example, in insolvency or because the board voted against indemnification), Side A protects the director's personal assets. Side A is the most critical coverage for individual directors.
- Aggregate limits. Israeli D&O policies for private companies typically carry aggregate limits of NIS 5 million to NIS 50 million (approximately USD 1.4 million to USD 14 million at current rates). Assess whether the limit is adequate for the company's size and litigation risk profile.
Most Israeli D&O policies do not cover Section 119A ITA assessments for unpaid tax, because these are statutory personal obligations rather than civil liability arising from a wrongful act as director. Similarly, wage claims under Section 29 of the Wage Protection Law may fall outside the policy if the insurer treats them as employment practice liability rather than D&O liability. Before accepting a directorship, ask the Israeli company's insurance broker to confirm in writing whether Section 119A exposure and wage claim personal liability are covered under the current D&O policy, and what the response timeline is if a claim is threatened. If they are not covered, a separate employment practices liability (EPL) policy or a tax indemnity arrangement with the parent company is advisable.
9. Practical Steps for Foreign Directors
Most of the personal exposure foreign directors face is preventable. The following checklist covers the steps that matter most:
- Review the articles of association before accepting the appointment. Confirm that a duty-of-care release (Section 259) and an advance indemnification undertaking (Section 253) are in place. If not, insist on a general meeting to add them before your first board meeting.
- Confirm D&O coverage. Request a copy of the policy schedule and verify that Israeli subsidiary directorship is covered, that the territorial scope is global, and that Side A coverage is adequate for the litigation risk the company faces.
- Establish a conflict register. Before each board meeting, submit a written disclosure of any personal interests in agenda items — including items that involve the parent company. Record your abstention from any vote where you have a conflict.
- Read all board materials in advance. Document questions you raised about significant transactions — by email if not by voice at the meeting. The contemporaneous paper trail is your main evidence in any later proceeding.
- Verify payroll and withholding tax compliance. Once a year, ask the Israeli company's CFO or accountant for written confirmation that all employee income tax withholdings (nikui bemkor) and bituach leumi contributions have been remitted to date. This confirms your Section 119A exposure is current.
- Monitor the company's financial position. If the company begins to run at a material loss, escalate to the board in writing. A director who identifies distress and takes no action faces greater exposure than one who flagged it and pushed for restructuring or an orderly wind-down.
- Resign properly if you are leaving. Under Section 228 of the Companies Law, a director's resignation takes effect 48 hours after written notice is given to the company's registered address (or the date stated in the notice if later). Resignation only from the next meeting is insufficient — file written notice with the Israeli company secretary and ensure the resignation is filed with the Companies Registrar (Rash HaChavarot) promptly, because your name remains on the public register until it is.
A foreign director who discovers that an Israeli subsidiary has been accumulating unpaid employee taxes or wage obligations — and wants to resign — cannot simply walk away and assume liability stops at the resignation date. Israeli courts and the ITA have imposed Section 119A liability on directors for obligations that arose before resignation if the director knew or should have known of the problem before resigning. The safest course is to raise the issue formally at a board meeting, document the discussion and any proposed remediation plan, and only resign if the board declines to act — with that refusal in the minutes. In insolvency scenarios, consult an Israeli insolvency lawyer before resigning, since a resignation that triggers the company's default on a loan covenant could itself create liability under the wrongful trading doctrine.